Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-05-13, Stock:LLY, The news for the past five days is as follows:
2020-05-06: NEWS1: Tyvyt® (Sintilimab Injection) Combined with Gemzar® (Gemcitabine for Injection) and Platinum Chemotherapy Met the Predefined Primary Endpoint in the Phase 3 ORIENT-12 Study as First-Line Therapy in Patients with Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer.NEWS2: Myriad Genetics (MYGN) Lags Q3 Earnings Estimates, Cancels View.NEWS3: CVS Health (CVS) Q1 Earnings Top Estimates, Costs Escalate.NEWS4: Jazz Pharma (JAZZ) Misses on Q1 Earnings & Sales, Cuts View.NEWS5: Haemonetics (HAE) Q4 Earnings Lag Estimates, Margins Expand.NEWS6: Inogen's (INGN) Q1 Earnings and Revenues Beat Estimates.NEWS7: DaVita (DVA) Earnings and Revenues Beat Estimates in Q1.NEWS8: After Its Strong First-Quarter Results, Should You Buy Shares of Eli Lilly?.NEWS9: PerkinElmer (PKI) Q1 Earnings and Revenues Surpass Estimates.NEWS10: Why These 8 Pharma Stocks Are Outplaying 90% Of The Stock Market.
2020-05-07: NEWS1: Amedisys (AMED) Q1 Earnings Beat, Operating Margin Falls.NEWS2: QIAGEN (QGEN) Q1 Earnings Lag Estimates, Operating Margin Up.NEWS3: AmerisourceBergen (ABC) Q2 Earnings & Revenues Top Estimates.NEWS4: Bio-Rad (BIO) Beats Q1 Earnings Estimates, Withdraws View.NEWS5: Exact Sciences' (EXAS) Q1 Earnings Fall Y/Y, Margin Expands.NEWS6: Nevro (NVRO) Earnings and Revenues Beat Estimates in Q1.NEWS7: Becton Dickinson (BDX) Q2 Earnings and Revenues Top Estimates.NEWS8: Bristol Myers sees 2020 earnings holding despite coronavirus pandemic.NEWS9: Express Scripts' 'Parachute' to cap prescription costs for those hit by coronavirus turmoil.
2020-05-08: NEWS1: FDA approves Eli Lilly drug for thyroid, lung cancers driven by a genetic mutation.NEWS2: NIAID to Test Gilead's Remdesivir Together with Lilly's Olumiant for Coronavirus.NEWS3: NIAID to Test Gilead's Remdesivir Together with Lilly's Olumiant for Coronavirus.NEWS4: Government to test remdesivir with Lilly drug in COVID-19 patients.NEWS5: NIH begins study of remdesivir with anti-inflammatory drug to treat COVID-19.NEWS6: Higher investigational doses of Trulicity® (dulaglutide) meaningfully reduced A1C and body weight in people with type 2 diabetes.NEWS7: 5 Biopharmas Where BofA Would Put Its Money To Work.NEWS8: Pharma Stock Roundup: Q1 Earnings of BMY, NVO, Coronavirus Update From PFE, RHHBY.NEWS9: OPKO Health (OPK) Reports Q1 Loss, Lags Revenue Estimates.NEWS10: Globus Medical (GMED) Misses on Q1 Earnings and Revenues.NEWS11: Omnicell (OMCL) Q1 Earnings Top, Operating Margin Rises.NEWS12: Avanos Medical (AVNS) Q1 Earnings Lag Estimates, Revenues Top.NEWS13: DENTSPLY SIRONA (XRAY) Posts Weak Q1 Preliminary Results.NEWS14: Integra (IART) Lags Q1 Earnings Estimates, Withdraws Outlook.NEWS15: Glaukos (GKOS) Q1 Earnings and Revenues Miss Estimates.NEWS16: Bruker (BRKR) Q1 Earnings Miss Estimates, Guidance Suspended.NEWS17: 3 Big Stock Charts for Friday: Bristol-Myers Squibb, Eli Lilly, and GlaxoSmithKline.NEWS18: Pacific Biosciences (PACB) Q1 Earnings Surpass Estimates.
2020-05-11: NEWS1: LLY Stock Approaching Support: Here Are Two Option Trade Ideas.NEWS2: A Triangle Formation on Drug Maker Eli Lilly Is Ready for an Upside Breakout.NEWS3: Zimmer Biomet (ZBH) Q1 Earnings Top, Revenues Miss Estimates.NEWS4: Insulet (PODD) Q1 Earnings Lag Estimates, Margins Decline.NEWS5: Fresenius Medical (FMS) Q1 Earnings Miss Estimates, Fall Y/Y.NEWS6: Cardinal Health (CAH) Beats Q3 Earnings and Revenue Estimates.NEWS7: LHC Group (LHCG) Earnings and Revenues Beat Estimates in Q1.
2020-05-12: NEWS1: Allscripts (MDRX) Q1 Earnings and Revenues Miss Estimates.NEWS2: National Vision (EYE) Q1 Earnings Top Estimates, Margin Falls.NEWS3: Integer Holdings (ITGR) Q1 Earnings & Revenues Top Estimates.NEWS4: ESG Stocks Remain Resilient to Virus Slump: 5 Top Picks.NEWS5: China's Junshi Bio, Lilly to Co-Develop Covid-19 Antibody Therapies.

Answer: Rise